KB
Therapeutic Areas
Sequoia Vaccines Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SEQ-400 | Prevention of Recurrent Urinary Tract Infections (UTIs) | Phase 1 |
| SEQ-1274 Platform | Ovarian/Uterine Cancer | Pre-clinical |
| Novel Analog Platform | Lung Infections in Cystic Fibrosis | Pre-clinical |